Role of CCR2 in inflammatory conditions of the central nervous system
Standard
Role of CCR2 in inflammatory conditions of the central nervous system. / Chu, Hannah X; Arumugam, Thiruma V; Gelderblom, Mathias; Magnus, Tim; Drummond, Grant R; Sobey, Christopher G.
in: J CEREBR BLOOD F MET, Jahrgang 34, Nr. 9, 01.09.2014, S. 1425-9.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Role of CCR2 in inflammatory conditions of the central nervous system
AU - Chu, Hannah X
AU - Arumugam, Thiruma V
AU - Gelderblom, Mathias
AU - Magnus, Tim
AU - Drummond, Grant R
AU - Sobey, Christopher G
PY - 2014/9/1
Y1 - 2014/9/1
N2 - CC chemokine receptor 2 (CCR2) plays important roles in extravasation and transmigration of monocytes under inflammatory conditions. CCR2 and its ligands have been extensively studied in a range of inflammatory diseases in the central nervous system (CNS), including multiple sclerosis, Alzheimer's disease and ischemic stroke. This brief review summarizes our current understanding of the physiologic and pathologic roles of CCR2, focusing on its involvement in CNS inflammatory diseases. There appears to be a rationale for exploring therapies involving CCR2 inhibition in multiple sclerosis and ischemic stroke, but there is also evidence for immunomodulatory and protective effects of CCR2 activity during CNS inflammation. The critical balance between protective and detrimental roles of CCR2-dependent recruitment of leukocytes must therefore be carefully examined to guide safe and effective development of any therapies involving CCR2 modulation.
AB - CC chemokine receptor 2 (CCR2) plays important roles in extravasation and transmigration of monocytes under inflammatory conditions. CCR2 and its ligands have been extensively studied in a range of inflammatory diseases in the central nervous system (CNS), including multiple sclerosis, Alzheimer's disease and ischemic stroke. This brief review summarizes our current understanding of the physiologic and pathologic roles of CCR2, focusing on its involvement in CNS inflammatory diseases. There appears to be a rationale for exploring therapies involving CCR2 inhibition in multiple sclerosis and ischemic stroke, but there is also evidence for immunomodulatory and protective effects of CCR2 activity during CNS inflammation. The critical balance between protective and detrimental roles of CCR2-dependent recruitment of leukocytes must therefore be carefully examined to guide safe and effective development of any therapies involving CCR2 modulation.
KW - Animals
KW - Brain Diseases
KW - Humans
KW - Monocytes
KW - Multiple Sclerosis
KW - Receptors, CCR2
KW - Transendothelial and Transepithelial Migration
U2 - 10.1038/jcbfm.2014.120
DO - 10.1038/jcbfm.2014.120
M3 - SCORING: Journal article
C2 - 24984897
VL - 34
SP - 1425
EP - 1429
JO - J CEREBR BLOOD F MET
JF - J CEREBR BLOOD F MET
SN - 0271-678X
IS - 9
ER -